The Lundquist Institute at UCLA's Geffen Medical School has received an additional $3 million from the National Institutes of Health to expand a male contraceptive study, the school announced today.
/PRNewswire/ The Lundquist Institute announced that its Male Contraceptive Efficacy Trial has received an additional $3 million from the National Institutes.
/PRNewswire/ The Lundquist Institute announced that its Male Contraceptive Efficacy Trial has received an additional $3 million from the National Institutes.
In a new paper published by Nature Communications, The Lundquist Institute (TLI) Investigator Wei Yan, MD, PhD, and his research colleagues spell out an innovative strategy that has led to the discovery of a natural compound as a safe, effective and reversible male contraceptive agent in pre-clinical animal models